Processa Pharmaceuticals, Inc. PCSA
1.86 USD -0.01 (-0.53%)
Nov 11, 2026, 10:47 AM EST
1.86 Day range 1.90
1.04 52-week range 8.88
- YTD
- -35.42%
- 1 year
- -76.46%
PCSA revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-12-31 | 0 | 0 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | -113,425 | -100.00% |
| FY 2015 | 2015-12-31 | 113,425 | 6,186 | 5.77% |
| FY 2014 | 2014-12-31 | 107,239 | -205,241 | -65.68% |
| FY 2013 | 2013-12-31 | 312,480 | 120,335 | 62.63% |
| FY 2012 | 2012-12-31 | 192,145 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:42.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.